vs
Chatham Lodging Trust（CLDT）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Chatham Lodging Trust的1.1倍（$75.5M vs $67.7M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -9.8%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -0.5%）
查塔姆住宿信托是一家专注于投资、持有及运营高端长住型和精选服务类酒店物业的房地产投资信托，主要布局美国高需求的城市及城郊市场，服务商务与休闲旅客群体，追求长期稳定的现金流收益。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CLDT vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$67.7M
营收增速更快
PBYI
高出37.5%
-9.8%
两年增速更快
PBYI
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.7M | $75.5M |
| 净利润 | $4.6M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 15.9% | 22.7% |
| 净利率 | 6.8% | — |
| 营收同比 | -9.8% | 27.7% |
| 净利润同比 | 369.9% | — |
| 每股收益（稀释后） | $0.05 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLDTPBYI
| Q4 25 | $67.7M | $75.5M | ||
| Q3 25 | $78.4M | $54.5M | ||
| Q2 25 | $80.3M | $52.4M | ||
| Q1 25 | $68.6M | $46.0M | ||
| Q4 24 | $75.1M | $59.1M | ||
| Q3 24 | $87.2M | $80.5M | ||
| Q2 24 | $86.5M | $47.1M | ||
| Q1 24 | $68.4M | $43.8M |
净利润CLDTPBYI
| Q4 25 | $4.6M | — | ||
| Q3 25 | $3.5M | $8.8M | ||
| Q2 25 | $5.4M | $5.9M | ||
| Q1 25 | $1.5M | $3.0M | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $4.3M | $20.3M | ||
| Q2 24 | $6.8M | $-4.5M | ||
| Q1 24 | $-5.2M | $-4.8M |
毛利率CLDTPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | 40.7% | 76.4% | ||
| Q3 24 | 44.7% | 63.9% | ||
| Q2 24 | 46.1% | 77.4% | ||
| Q1 24 | 38.9% | 75.5% |
营业利润率CLDTPBYI
| Q4 25 | 15.9% | 22.7% | ||
| Q3 25 | 12.7% | 17.6% | ||
| Q2 25 | 14.8% | 12.7% | ||
| Q1 25 | 12.1% | 8.7% | ||
| Q4 24 | 7.5% | 22.6% | ||
| Q3 24 | 14.3% | 27.4% | ||
| Q2 24 | 16.3% | -4.6% | ||
| Q1 24 | 1.4% | -5.3% |
净利率CLDTPBYI
| Q4 25 | 6.8% | — | ||
| Q3 25 | 4.5% | 16.2% | ||
| Q2 25 | 6.7% | 11.2% | ||
| Q1 25 | 2.2% | 6.5% | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 4.9% | 25.2% | ||
| Q2 24 | 7.9% | -9.6% | ||
| Q1 24 | -7.6% | -11.0% |
每股收益（稀释后）CLDTPBYI
| Q4 25 | $0.05 | $0.26 | ||
| Q3 25 | $0.03 | $0.17 | ||
| Q2 25 | $0.07 | $0.12 | ||
| Q1 25 | $-0.01 | $0.06 | ||
| Q4 24 | $-0.08 | $0.40 | ||
| Q3 24 | $0.05 | $0.41 | ||
| Q2 24 | $0.10 | $-0.09 | ||
| Q1 24 | $-0.15 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.4M | $97.5M |
| 总债务越低越好 | $338.9M | $22.7M |
| 股东权益账面价值 | $740.8M | $130.3M |
| 总资产 | $1.2B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.46× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CLDTPBYI
| Q4 25 | $24.4M | $97.5M | ||
| Q3 25 | $13.2M | $94.4M | ||
| Q2 25 | $17.2M | $96.0M | ||
| Q1 25 | $18.6M | $93.2M | ||
| Q4 24 | $20.2M | $101.0M | ||
| Q3 24 | $19.3M | $96.7M | ||
| Q2 24 | $10.6M | $96.8M | ||
| Q1 24 | $72.3M | $107.2M |
总债务CLDTPBYI
| Q4 25 | $338.9M | $22.7M | ||
| Q3 25 | $338.8M | $34.0M | ||
| Q2 25 | $351.2M | $45.3M | ||
| Q1 25 | $381.1M | $56.7M | ||
| Q4 24 | $406.9M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益CLDTPBYI
| Q4 25 | $740.8M | $130.3M | ||
| Q3 25 | $749.4M | $115.3M | ||
| Q2 25 | $754.1M | $104.7M | ||
| Q1 25 | $754.7M | $97.1M | ||
| Q4 24 | $758.2M | $92.1M | ||
| Q3 24 | $765.3M | $71.1M | ||
| Q2 24 | $766.5M | $48.5M | ||
| Q1 24 | $765.0M | $51.0M |
总资产CLDTPBYI
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.2B | $202.9M | ||
| Q2 25 | $1.2B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.3B | $213.3M | ||
| Q3 24 | $1.3B | $220.7M | ||
| Q2 24 | $1.3B | $205.0M | ||
| Q1 24 | $1.3B | $214.1M |
负债/权益比CLDTPBYI
| Q4 25 | 0.46× | 0.17× | ||
| Q3 25 | 0.45× | 0.30× | ||
| Q2 25 | 0.47× | 0.43× | ||
| Q1 25 | 0.50× | 0.58× | ||
| Q4 24 | 0.54× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $64.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 13.90× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流CLDTPBYI
| Q4 25 | $64.1M | $14.4M | ||
| Q3 25 | $25.6M | $9.7M | ||
| Q2 25 | $22.1M | $14.1M | ||
| Q1 25 | $4.2M | $3.6M | ||
| Q4 24 | $73.8M | $15.6M | ||
| Q3 24 | $28.8M | $11.0M | ||
| Q2 24 | $25.2M | $1.0M | ||
| Q1 24 | $6.9M | $11.2M |
自由现金流CLDTPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率CLDTPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度CLDTPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率CLDTPBYI
| Q4 25 | 13.90× | — | ||
| Q3 25 | 7.24× | 1.10× | ||
| Q2 25 | 4.10× | 2.41× | ||
| Q1 25 | 2.73× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.78× | 0.54× | ||
| Q2 24 | 3.68× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLDT
| Occupancy | $61.5M | 91% |
| Hotel Other | $4.2M | 6% |
| Food And Beverage | $1.8M | 3% |
| Hotel | $1.1M | 2% |
PBYI
暂无分部数据
